Abstract
Gene fusion is a key factor in sarcomas, lymphomas, leukemias and so on. In order to help biologist to discover the target of the treatment, we developed VFP to predict gene-fusion from single-end RNA-sequencing reads. VFP employs seed index strategy and octal encoding operations for sequence alignments. By using several rules to score and filter the potential fusion genes, VFP could detect known and novel fusions through a series of tests on lymphoma and melanoma RNA-sequencing datasets.
Keywords: Gene, fusion, algorithm, next generation sequencing.
Current Bioinformatics
Title:VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data
Volume: 11 Issue: 1
Author(s): Ye Yang and Juan Liu
Affiliation:
Keywords: Gene, fusion, algorithm, next generation sequencing.
Abstract: Gene fusion is a key factor in sarcomas, lymphomas, leukemias and so on. In order to help biologist to discover the target of the treatment, we developed VFP to predict gene-fusion from single-end RNA-sequencing reads. VFP employs seed index strategy and octal encoding operations for sequence alignments. By using several rules to score and filter the potential fusion genes, VFP could detect known and novel fusions through a series of tests on lymphoma and melanoma RNA-sequencing datasets.
Export Options
About this article
Cite this article as:
Yang Ye and Liu Juan, VFP: A Visual Algorithm for Predicting Gene Fusion in RNA-Seq Data, Current Bioinformatics 2016; 11 (1) . https://dx.doi.org/10.2174/1574893611888151222162228
DOI https://dx.doi.org/10.2174/1574893611888151222162228 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Proteases and their Receptors as Mediators of Inflammation-Associated Colon Cancer
Current Pharmaceutical Design Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy
Current Pharmaceutical Design Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Defects in RNA Metabolism links FTD and ALS Pathogenesis: TDP-43, FUS, and C9orf72
Current Enzyme Inhibition Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum
Current Medicinal Chemistry Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design Antibody Gene Therapy: Getting Closer to Clinical Application?
Current Gene Therapy Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
Current Pharmaceutical Design Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism Antiproliferative and Genotoxic Action of an Underexploited Organoteluran Derivative on Sarcoma 180 Cells
Anti-Cancer Agents in Medicinal Chemistry The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Current Status and Perspectives Regarding the Treatment of Osteosarcoma: Chemotherapy
Reviews on Recent Clinical Trials Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology Nanocarrier based Antiretroviral Drug Delivery Approaches
Pharmaceutical Nanotechnology MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Capsid Assembly as a Point of Intervention for Novel Anti-viral Therapeutics
Current Pharmaceutical Biotechnology